Tower Research Capital (TRC)’s Motif Bio plc ADRs MTFB Stock Holding History

Tower Research Capital (TRC)’s Portfolio MTFB Stock Details MTFB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-100	Closed	-$1K	–	4322
2018 Q1	$1K	Buy	+100	New	+$1.03K	﹤0.01%	3144
2017 Q3	–	Sell	-66	Closed	-$1K	–	4335
2017 Q2	$1K	Buy	66 +16	+32%	+$132	﹤0.01%	2575
2017 Q1	$0	Sell	50 -50	-50%	-$313	﹤0.01%	4321
2016 Q4	$1K	Buy	+100	New	+$582	﹤0.01%	3716

Other funds holding MTFB

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Tower Research Capital (TRC)'s MTFB Position: Q2 2018 in Review

Tower Research Capital (TRC) sold out of Motif Bio plc ADRs (MTFB) in Q2 2018, closing a stake of 100 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in MTFB in Q4 2016 and held it in 4 quarters. The position peaked at $1K in Q1 2018. 2 funds tracked by Wall St. Rank hold MTFB as of Q2 2018.

Tower Research Capital (TRC) reported no remaining Motif Bio plc ADRs position as of Q2 2018 after selling out during the quarter.
Tower Research Capital (TRC) sold 100 Motif Bio plc ADRs shares in Q2 2018, an estimated $1K.
Tower Research Capital (TRC) first reported a position in Motif Bio plc ADRs in Q4 2016 and held it in 4 quarters.
Tower Research Capital (TRC)'s Motif Bio plc ADRs position peaked at $1K in Q1 2018.
2 funds tracked by Wall St. Rank held Motif Bio plc ADRs as of Q2 2018.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2018, filed 15 Aug 2018.